BioSpace News Archive

Drug Development

ProEthic Pharmaceuticals, Inc. Initiates Pivotal Phase III Trial For Fast-Acting Migraine Product Candidate

May 22, 2006
·
1 min read
FDA

Lannett Company, Inc. Receives Approval For Probenecid Tablets 500 mg, USP

May 22, 2006
·
1 min read
BioMidwest

TAP Pharmaceutical Products Inc. Foundation Establishes TAP Research Endowment Fund

May 22, 2006
·
4 min read
Biotech Bay

Integrated Healthcare Association Receives Grant To Fund Project To Improve Adoption And Use Of New Medical Devices

May 22, 2006
·
2 min read
Drug Development

Novartis Pharmaceuticals Corporation Release: Study Reveals Zelnorm(R) May Be A Safe And Effective Treatment For Additional Group Of IBS Patients With A Mixed Bowel Pattern

May 22, 2006
·
8 min read
Business

Martek Biosciences Corporation To Announce Second Quarter 2006 Results On June 6, 2006

May 22, 2006
·
1 min read
BioMidwest

MedicalCV Inc. Announces One-For-Ten Reverse Stock Split And Files Application To List Stock On Nasdaq Capital Market

May 22, 2006
·
1 min read
Drug Development

Promising Pivotal Phase III Data Show Abbott Laboratories’s Humira(R) (Adalimumab) Maintained Clinical Remission In Patients With Crohn’s Disease Through One Year

May 22, 2006
·
9 min read
Biotech Beach

AstraZeneca PLC Release: Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome

May 22, 2006
·
6 min read
Drug Development

Sepracor, Inc. Announces Presentation Of Lunesta(TM) Data At American Psychiatric Association Annual Meeting

May 22, 2006
·
1 min read